Literature DB >> 15640261

Pulmonary regurgitation: not a benign lesion.

Beatriz Bouzas1, Philip J Kilner, Michael A Gatzoulis.   

Abstract

Pulmonary regurgitation (PR) is a common complication after surgical or percutaneous relief of pulmonary stenosis and following repair of tetralogy of Fallot. Significant PR is usually well tolerated in childhood. However, in the long term, chronic PR has a detrimental effect on right ventricular (RV) function and exercise capacity and leads to an increased risk of arrhythmia and sudden cardiac death (SCD). Recent advances in non-invasive imaging and, in particular, wider availability of cardiovascular magnetic resonance (CMR), have improved the assessment of PR and RV function in these patients. This in turn has facilitated decision making on the optimal timing for elective pulmonary valve replacement (PVR), which should be performed before irreversible RV dysfunction ensues.

Entities:  

Mesh:

Year:  2005        PMID: 15640261     DOI: 10.1093/eurheartj/ehi091

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  52 in total

1.  Clinical value of Tei index in pediatric patients with repaired tetralogy of Fallot.

Authors:  Bing Song; Quan Qi; Ruisheng Liu; Wang Xing; Hanbo Tang; Yuanmin Li
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Preliminary Assessment of Tricuspid Valve Annular Velocity Parameters by Cardiac Magnetic Resonance Imaging in Adults with a Volume-Overloaded Right Ventricle: Comparison of Unrepaired Atrial Septal Defect and Repaired Tetralogy of Fallot.

Authors:  Seiji Ito; Doff B McElhinney; Robert Adams; Puneet Bhatla; Sohae Chung; Leon Axel
Journal:  Pediatr Cardiol       Date:  2015-04-04       Impact factor: 1.655

Review 3.  Tetralogy of Fallot: from fetus to adult.

Authors:  Elliot A Shinebourne; Sonya V Babu-Narayan; Julene S Carvalho
Journal:  Heart       Date:  2006-09       Impact factor: 5.994

4.  Evaluation of Hybrid Surgical Access Approaches for Pulmonary Valve Implantation in an Acute Swine Model.

Authors:  Ruth Thalmann; Elena M Merkel; Bassil Akra; Rene Bombien; Rainer G Kozlik-Feldmann; Christoph Schmitz
Journal:  Comp Med       Date:  2019-06-20       Impact factor: 0.982

5.  Assessing utility of exercise test in determining exercise prescription in adolescent and adult patients with repaired tetralogy of fallot.

Authors:  Ming-Chun Yang; Chun-An Chen; Hsin-Hui Chiu; Jou-Kou Wang; Ming-Tai Lin; Shuenn-Nan Chiu; Chun-Wei Lu; Shu-Chien Huang; Mei-Hwan Wu
Journal:  Heart Vessels       Date:  2016-06-06       Impact factor: 2.037

6.  Use of oversized injectable valves in growing children for total repair of right ventricular outflow tract anomalies (preliminary results).

Authors:  Luca Deorsola; Pietro Angelo Abbruzzese
Journal:  Tex Heart Inst J       Date:  2014-08-01

Review 7.  Pulmonic Valve Disease: Review of Pathology and Current Treatment Options.

Authors:  Mouhammad Fathallah; Richard A Krasuski
Journal:  Curr Cardiol Rep       Date:  2017-09-16       Impact factor: 2.931

8.  Delayed onset of tricuspid valve flow in repaired tetralogy of Fallot: an additional mechanism of diastolic dysfunction and interventricular dyssynchrony.

Authors:  Ai-Min Sun; Fahad AlHabshan; Michael Cheung; Gabriele Bronzetti; Andrew N Redington; Lee N Benson; Christopher Macgowan; Shi-Joon Yoo
Journal:  J Cardiovasc Magn Reson       Date:  2011-08-24       Impact factor: 5.364

9.  Quantification of pulmonary regurgitation and prediction of pulmonary valve replacement by echocardiography in patients with congenital heart defects in comparison to cardiac magnetic resonance imaging.

Authors:  Claudia Dellas; Laura Kammerer; Verena Gravenhorst; Joachim Lotz; Thomas Paul; Michael Steinmetz
Journal:  Int J Cardiovasc Imaging       Date:  2017-11-08       Impact factor: 2.357

10.  Assessment of intracardiac flow and vorticity in the right heart of patients after repair of tetralogy of Fallot by flow-sensitive 4D MRI.

Authors:  Daniel Hirtler; Julio Garcia; Alex J Barker; Julia Geiger
Journal:  Eur Radiol       Date:  2016-01-08       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.